Patents by Inventor Diego COPELLI

Diego COPELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277451
    Abstract: The present invention generally relates to pharmaceutical composition comprising a LABA agent, optionally in combination with other active ingredients, a mixture of at least two inorganic acids, a propellant and a co-solvent. The invention also provides a pharmaceutical composition for the treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: October 8, 2021
    Publication date: September 7, 2023
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Enrico ZAMBELLI, Sauro BONELLI, Diego COPELLI, Massimiliano DAGLI ALBERI, Francesca USBERTI
  • Publication number: 20220395454
    Abstract: The invention generally refers to a stainless steel can for use in a metered dose inhaler device, containing an aerosol formulation, comprising glycopyrronium bromide and formoterol, or a salt or a solvate thereof, optionally in combination with one or more additional active ingredient, endowed with a high stability.
    Type: Application
    Filed: December 2, 2019
    Publication date: December 15, 2022
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Enrico ZAMBELLI, Sauro BONELLI, Diego COPELLI, Massimiliano DAGLI ALBERI, Francesca USBERTI
  • Patent number: 11426538
    Abstract: An actuator for a pressurized metered dose inhaler providing a significant reduction in the non-respirable coarse fraction of the emitted aerosol medicament impacting in the oro-pharynx, with consequent less associated side effects and oral candidiasis in the patient, due to the fact that the mouthpiece portion has a central rounded opening of a well-defined width and distance from the nozzle aperture and also provided with a cylindrical recess, whose central axis is aligned with the central longitudinal axis of the mouthpiece portion and with the central longitudinal axis of the nozzle channel.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: August 30, 2022
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Diego Copelli, Andrea Casazza
  • Patent number: 10617669
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Patent number: 10617638
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Patent number: 10596113
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: March 24, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Patent number: 10596149
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: March 24, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Publication number: 20170281885
    Abstract: Actuators for a pressurised metered dose inhalers containing (a) a housing adapted to receive an aerosol canister containing a pressurised medicament formulation, (b) a nozzle block defining the receptacle for the aerosol canister valve stem, the expansion chamber or sump, the nozzle channel its external aperture, and (c) a mouthpiece portion comprising a central rounded opening of a defined width and distance from the nozzle aperture and a cylindrical recess, whose central axis is aligned with the central longitudinal axis of the mouthpiece portion and with the central longitudinal axis of the nozzle channel, provide a significant reduction in the non-respirable coarse fraction of the emitted aerosol medicament via inertial impaction and retention in the actuator rather than in the oro-pharynx, with consequent less associated side effects and oral candidiasis in the patient.
    Type: Application
    Filed: March 31, 2017
    Publication date: October 5, 2017
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Diego Copelli, Andrea Casazza
  • Publication number: 20170095444
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: December 15, 2016
    Publication date: April 6, 2017
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • Publication number: 20160303044
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro BONELLI, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Publication number: 20160303045
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Applicant: CHIESI FARMACEUTICI S.P.A
    Inventors: Sauro BONELLI, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Publication number: 20150182450
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • Publication number: 20150182459
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI